Alexey Strygin

Alexey Strygin is a bioentrepreneur primarily focused on advancing longevity biotechnology and extending healthy human lifespan.13 He served as the CEO and co-founder of Gray Matter, a company that developed therapeutic peptides aimed at addressing age-related cognitive decline and longevity.2

Professional Experience

Strygin's career has been centered around the field of longevity and biotechnology:

• Gray Matter: CEO and co-founder (2021-2022)7
• Cryno: CEO (2016-2020)7
• Skolkovo Foundation: Analyst (2013-2015)7

Current Role

As of the most recent information available, Alexey Strygin is associated with Gero, a company likely involved in longevity research and biotechnology.1

Expertise and Focus

Strygin's areas of expertise include:

• Longevity biotechnology
• Drug discovery
• Business development
• Startups
• Longevity economics5

He is particularly interested in AI drug discovery and biomarkers for human longevity.6

Education

Alexey Strygin received his education from Oxford Brookes University.1

Professional Network

Strygin is active in the longevity research community and has participated in panel discussions alongside notable figures in the field, such as Aubrey de Grey, Eleanor Davies, Tina Woods, Lynne Corner, and Peter Ward.4

Alexey Strygin's LinkedIn username is alexey-strygin-93030024, as mentioned in the query.